Neuberger Berman Group
ALLO icon

Neuberger Berman Group’s Allogene Therapeutics ALLO Stock Holding History

Neuberger Berman Group’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.2K Buy
+14,825
New +$29.7K ﹤0.01% 2126
2025
Q2 		– Sell
-16,621
Closed -$24.3K – 2053
2025
Q1 		$24.3K Buy
+16,621
New +$31.3K ﹤0.01% 1933
2021
Q4 		– Sell
-8,085
Closed -$208K – 1907
2021
Q3 		$208K Hold
8,085
– – ﹤0.01% 1685
2021
Q2 		$211K Sell
8,085
-8,161
-50% -$233K ﹤0.01% 1700
2021
Q1 		$574K Sell
16,246
-555
-3% -$18.7K ﹤0.01% 1451
2020
Q4 		$431K Buy
16,801
+891
+6% +$29K ﹤0.01% 1429
2020
Q3 		$613K Buy
15,910
+1,650
+12% +$62.2K ﹤0.01% 1313
2020
Q2 		$610K Buy
14,260
+660
+5% +$23.9K ﹤0.01% 1243
2020
Q1 		$265K Buy
+13,600
New +$324K ﹤0.01% 1368

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return